©The Author(s) 2018.
World J Hepatol. May 27, 2018; 10(5): 417-424
Published online May 27, 2018. doi: 10.4254/wjh.v10.i5.417
Published online May 27, 2018. doi: 10.4254/wjh.v10.i5.417
Table 2 Medical conditions associated with non-obstructive sinusoidal dilatation
| Variables | n |
| Malignancy | |
| Hematological malignancies | |
| Leukemia | |
| AML | 2 |
| CLL | 1 |
| CML | 1 |
| Lymphoma | |
| B-cell lymphoma | 4 |
| T-cell lymphoma | 1 |
| Solid organ tumor | |
| Gastric adenocarcinoma | 2 |
| Angiosarcoma | 1 |
| Myeloproliferative disorder | 9 |
| Inflammatory condition | |
| Granulomatous hepatitis | 4 |
| Connective tissue disorder | 3 |
| Ulcerative colitis | 2 |
| Castleman’s disease | 2 |
| Polyarthritis nodosa | 2 |
| Other1 | 15 |
| Medications | |
| Oxaliplatin | 7 |
| Purine Analogs | 3 |
| Other2 | 9 |
- Citation: Sunjaya DB, Ramos GP, Braga Neto MB, Lennon R, Mounajjed T, Shah V, Kamath PS, Simonetto DA. Isolated hepatic non-obstructive sinusoidal dilatation, 20-year single center experience. World J Hepatol 2018; 10(5): 417-424
- URL: https://www.wjgnet.com/1948-5182/full/v10/i5/417.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i5.417